Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients-Reference-Cited by-同舟云学术

Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients

Published:2020-10 Issue:10 Volume:46 Page:e62-e70
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology
language:en
Short-container-title:European Journal of Surgical Oncology

Author:

Ke Jia,Liu Xuan-hui,Jiang Xiao-feng,He Zhen,Xiao Jian,Zheng Bin,Chen Yu-feng,Cai Ze-rong,Zheng Xiao-bin,Zou Yi-feng,Lan Ping,Wu Xiao-jian,Gao Feng^ORCID

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Science and Technology Planning Project of Guangdong Province

Guangdong Natural Science Foundation

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Glynne-Jones;Ann Oncol,2018

3. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients;Dienstmann;J Clin Oncol,2015

4. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors;Kopetz;Oncol,2015

5. hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy;Muratori;OncoTargets Ther,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A hot and cold tumor‑related prognostic signature for stage II colorectal cancer;Oncology Letters;2024-07-03

2. Prognostic significance of the Naples prognostic score in colorectal cancer patients undergoing curative resection: a propensity score matching analysis;BMC Gastroenterology;2023-03-25

3. An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer;Cancer Medicine;2023-01-11

4. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer;Frontiers in Endocrinology;2022-11-28

5. Prognostic value of the ratio of carcinoembryonic antigen concentration to maximum tumor diameter in patients with stage II colorectal cancer;Journal of Gastrointestinal Oncology;2021-08